Auxly Cannabis Group Inc.

XLY

CA05335P1099

Pharmaceuticals

Market Closed - Toronto S.E. Other stock markets 04:27:14 2025-07-11 pm EDT			5-day change	1st Jan Change
0.1300 ^CAD	-10.34%		0.00%	+225.00%

Jul. 08	Auxly Announces Restated Auxly Leamington's Existing Credit Facility Agreement	CI
Jul. 08	Auxly closes transformational debt reduction transactions	RE

Auxly Cannabis Group Brief: Announcing Non-Binding Agreement to Amend and Extend BMO Credit Facility and Settlement of all Amounts owing to Imperial Brands

Published on 06/19/2025 at 07:32

This article is reserved for members

Unlock the article: REGISTER NOW!

100% Free Registration

Already a customer? Log In

Latest news about Auxly Cannabis Group Inc.

Auxly Announces Restated Auxly Leamington's Existing Credit Facility Agreement	Jul. 08	CI
Auxly closes transformational debt reduction transactions	Jul. 08	RE
Auxly Announces Non-Binding Agreement to Amend and Extend BMO Credit Facility	Jun. 19	RE
Auxly Cannabis Enters Agreements to Strengthen Balance Sheet, Reduce Debt	Jun. 19	MT
Auxly Cannabis Group Inc. Enters Into Non-Binding Agreement To Amend And Extend BMO Credit Facility	Jun. 19	CI
Auxly Cannabis Group Brief: Announcing Non-Binding Agreement to Amend and Extend BMO Credit Facility and Settlement of all Amounts owing to Imperial Brands	Jun. 19	MT
Auxly Cannabis Group Inc. Reports Earnings Results for the First Quarter Ended March 31, 2025	May. 15	CI
Auxly Cannabis Swings to Q4 Profit On Higher Revenue	Mar. 20	MT
Auxly Cannabis Group Brief: Q4 Net revenue of $34.6 million, an increase of 29% over the prior year period	Mar. 20	MT
Auxly Cannabis Group Inc. Reports Earnings Results for the Full Year Ended December 31, 2024	Mar. 20	CI
Auxly Cannabis Group Inc. Auditor Raises 'Going Concern' Doubt	Mar. 19	CI
Auxly Cannabis Surges 22% on Revenue Jump, Record Q3 Adjusted Ebitda	Nov. 08	MT
Auxly Cannabis Group Brief: Q3 Net income of $3.2 million and cash flow provided by operating activities of $12.9 million	Nov. 08	MT
Auxly Cannabis Group Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024	Nov. 08	CI
Auxly Cannabis Jumps 11% as Swings to Q2 Profit on Record Revenue	24-08-15	MT
Auxly Cannabis Swings to Q2 Profit on Record Revenue	24-08-15	MT
Auxly Cannabis Group Brief: Q2 Net revenues of $29.2 million; Net income of $2.0 million	24-08-15	MT
Auxly Cannabis Group Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2024	24-08-15	CI
Auxly Cannabis Group Seeks Acquisitions	24-06-28	CI
Auxly Cannabis Group's Q1 Loss Widens Despite Record Revenue	24-05-13	MT
Correction: -- Auxly Cannabis Group Brief: Q1 Net Loss $26.012 Million	24-05-13	MT
Auxly Cannabis Group Brief: Q1 Net Loss 26,012 Million	24-05-13	MT
Auxly Cannabis Group Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	24-05-13	CI
Auxly Cannabis Products Now Available in Quebec	24-05-06	MT
Auxly Cannabis Group Brief: Announcing Expansion Into Quebec	24-05-06	MT

Chart Auxly Cannabis Group Inc.

Duration

Period

XLY: Dynamic Chart

Auxly Cannabis Group Inc. is a Canada-based consumer packaged goods company in the cannabis products market. The Company is focused on developing, manufacturing and distributing branded cannabis products. Its brands include Parcel, Back Forty, Foray, Dosecann and Kolab Project. It provides various products, including vaporizers, edibles, dried flowers, pre-rolls, capsules and oils and concentrates. The Company also conducts wholesale bulk sales of dried cannabis to various licensed producers in Canada. Its subsidiaries include Auxly Charlottetown Inc., Auxly Ottawa Inc., and Auxly Leamington Inc. The Companyâs primary Cannabis 2.0 Product development, manufacturing and R&D activities are conducted by its subsidiary Auxly Charlottetown Inc. at a cannabis processing facility located in Charlottetown, Prince Edward Island. Auxly Ottawa Inc. holds licenses for cultivation and processing and conducts the Companyâs primary dried flower and pre-roll manufacturing.

Employees

388

Sector

Pharmaceuticals

Calendar

Aug. 17 - Q2 2025 Earnings Release (Projected)

More about the company